Blue Wolf Capital Announces Expansion of Investment Team and Promotion of Joshua Cherry-Seto

Four Strategic Hires Support Continued Portfolio Growth

Shashank Patel Rejoins the Firm as Principal

Joshua Cherry-Seto Promoted to Managing Director

Blue Wolf Capital Partners ("Blue Wolf"), a New York-based private equity firm, today announced the expansion of its investment team with four strategic hires: Shashank Patel, Greg Singer, Ethan Cooper and David Meyers. Blue Wolf has also promoted Chief Financial Officer and Chief Compliance Officer Joshua Cherry-Seto to Managing Director.

Shashank Patel rejoins the firm as a Principal after working at Apax Partners and Providence Equity. He first joined Blue Wolf in 2011 and was previously involved in Blue Wolf’s investments in American Builders Supply, Snappy and Twin Rivers, among others.

In addition, Greg Singer, a recent MBA graduate from The Wharton School at the University of Pennsylvania and formerly a Private Equity Associate at Nautic Partners, joins the firm as a Senior Associate; Ethan Cooper, formerly an Analyst in the Middle Market Group at Lazard, joins the firm as an Associate; and, David Meyers, formerly an Investment Banking Analyst in the Restructuring Group at Perella Weinberg Partners, also joins the firm as an Associate.

Joshua Cherry-Seto has been promoted to Managing Director, reflecting his role in managing a wide variety of tax, legal, structuring, compliance and capital raising issues across the portfolio, as well as the commitment he has demonstrated to the firm’s ESG strategy since joining Blue Wolf in 2013. He will continue to remain Chief Financial Officer and Chief Compliance Officer.

"We are thrilled to add such a talented group of experienced individuals to our growing investment team – Shashank, Greg, Ethan and David will each play a critical role in supporting both new and existing investments across our portfolio," said Adam Blumenthal, Managing Partner of Blue Wolf Capital. "As we navigate this period of economic disruption, our team’s expansion not only reflects the continued growth of our investment pipeline in this environment, but it also ensures we are well-positioned to take advantage of the unique secular trends we expect to see accelerate in each of our investment verticals over the coming year."

"I am very excited to rejoin the Blue Wolf team at a time when the firm’s long-standing ESG-driven approach to value creation is more vital to investors and to society than perhaps ever before," said Shashank Patel, Principal at Blue Wolf Capital. "Working with Adam, Jeremy, Charlie, Bennet and other members of the Blue Wolf investment team was an important part of my career early on and I could not be more excited to be back at the firm today."

Most recently, Blue Wolf announced the sale of Pharmaceutical Strategies Group’s market-leading 340B business to Omnicell after a nine-year investment, reflecting the firm’s long-term ESG-driven approach to creating value. Last year, Blue Wolf also expanded its investment portfolio with the acquisitions of Fox Rehab, ClearSky Health, Kirlin Design Build, and RHA Health Services.

About Blue Wolf Capital Partners

Blue Wolf Capital Partners LLC is a private equity firm that specializes in control investments in middle market companies. Leading by experience, and with a commitment to excellence, Blue Wolf transforms companies strategically, operationally and collaboratively. Blue Wolf manages challenging situations and complex relationships between business, customers, employees, unions, and regulators to build value for stakeholders. For additional information, please visit www.bluewolfcapital.com.

Contacts

Media:

Kate Sylvester, ksylvester@sloanepr.com; 203-736-7821